17 Capital Partners, LLC Neurocrine Biosciences Inc Transaction History
17 Capital Partners, LLC
- $156 Million
- Q4 2024
A detailed history of 17 Capital Partners, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, 17 Capital Partners, LLC holds 1,710 shares of NBIX stock, worth $195,760. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,710
Previous 5,846
70.75%
Holding current value
$195,760
Previous $673,000
65.38%
% of portfolio
0.15%
Previous 0.44%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.62 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.16 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$560 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$345 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$291 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...